GENERAL ATLANTIC, L.P.
Q1 2025 13F Holdings
- Locationnew york, NY
- Num holdings
15
- Value ($000)
$2,979,034
- Date Filed05/14/2025
- Form type13F-HR
- CIK0001017645
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ALHC ALIGNMENT HEALTHCARE | COM | 01625V104 | $1.14B | 38 % | 60,993,323 | ||
DLOCAL | CL A | G29018101 | $532.98M | 18 % | 63,906,695 | ||
XP, INC | CL A | G98239109 | $407.24M | 14 % | 29,617,733 | ||
ALKT ALKAMI | COM | 01644J108 | $253.19M | 9 % | 9,645,318 | ||
AKRO AKERO THERAPEUTICS | COM | 00973Y108 | $211.87M | 7 % | 5,233,989 | ||
CNTA CENTESSA PHARMACEUTICALS | ADS | 152309100 | $139.22M | 5 % | 9,681,818 | ||
PHARVARIS | COM | N69605108 | $118.24M | 4 % | 7,531,252 | ||
EWCZ EUROPEAN WAX CENTER | CL A | 29882P106 | $51.79M | 2 % | 13,110,492 | ||
ROYALTY PHARMA | CL A | G7709Q104 | $46.70M | 2 % | 1,500,000 | ||
IMCR IMMUNOCORE | ADS | 45258D105 | $37.43M | 1 % | 1,261,684 |
Rows Per Page
10
- 10
- 50
- 100